[{"id":"15c0b879-53b2-4666-8984-e56ab2ab47db","acronym":"","url":"https://clinicaltrials.gov/study/NCT06041035","created_at":"2023-09-18T15:13:15.891Z","updated_at":"2024-07-02T16:35:36.709Z","phase":"Phase 1/2","brief_title":"A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT06041035","lead_sponsor":"Qilu Pharmaceutical Co., Ltd.","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • gemcitabine • capecitabine • albumin-bound paclitaxel • oxaliplatin • QLS31905"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 115","initiation":"Initiation: 10/01/2023","start_date":" 10/01/2023","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 10/01/2025","study_completion_date":" 10/01/2025","last_update_posted":"2023-09-18"}]